+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Central Venous Catheters (CVCs) - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 651 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5029781

Global Central Venous Catheters (CVCs) Market to Reach $1.6 Billion by 2027

Amid the COVID-19 crisis, the global market for Central Venous Catheters (CVCs) estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$1.6 Billion by 2027, growing at a CAGR of 5.4% over the period 2020-2027. Multi-Lumen, one of the segments analyzed in the report, is projected to record a 6.1% CAGR and reach US$793.9 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Triple-Lumen segment is readjusted to a revised 5.2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $388.2 Million, While China is Forecast to Grow at 7.1% CAGR

The Central Venous Catheters (CVCs) market in the U.S. is estimated at US$388.2 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$192 Million by the year 2027 trailing a CAGR of 7.1% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$173 Million by the year 2027.

Double-Lumen Segment to Record 4.7% CAGR

In the global Double-Lumen segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$159.1 Million in the year 2020 will reach a projected size of US$215.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 5.3% CAGR through the analysis period.

Select Competitors (Total 61 Featured)

  • Amecath
  • AngioDynamics Inc.
  • B. Braun Melsungen AG
  • Bactiguard AB
  • Becton, Dickinson and Company
  • COOK MEDICAL LLC
  • Edwards Lifesciences Corporation
  • Guangdong Baihe Medical Technology Co., Ltd
  • ICU Medical, Inc.
  • Insung Medical Co. Ltd.
  • KIMAL PLC
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Vygon Ltd
  • ZOLL Medical Corporation

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Central Venous Catheters (CVCs)

What is the estimated value of the Global Market for Central Venous Catheters (CVCs)?

The Global Market for Central Venous Catheters (CVCs) was estimated to be valued at $1.1 Billion in 2020.

What is the growth rate of the Global Market for Central Venous Catheters (CVCs)?

The growth rate of the Global Market for Central Venous Catheters (CVCs) is 5.5%, with an estimated value of $1.6 Billion by 2027.

What is the forecasted size of the Global Market for Central Venous Catheters (CVCs)?

The Global Market for Central Venous Catheters (CVCs) is estimated to be worth $1.6 Billion by 2027.

Who are the key companies in the Global Market for Central Venous Catheters (CVCs)?

Key companies in the Global Market for Central Venous Catheters (CVCs) include Amecath, AngioDynamics Inc., B. Braun Melsungen AG, Bactiguard AB, Becton, Dickinson and Company, COOK MEDICAL LLC, Edwards Lifesciences Corporation, Guangdong Baihe Medical Technology Co., Ltd and Insung Medical Co. Ltd..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Central Venous Catheters (CVCs) - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of COVID-19 Pandemic and Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Pandemic Disrupts Operations of Medical Equipment and Supplies Industry
  • Elective Surgeries Report Roller-Coaster Ride Amid COVID-19
  • COVID-19 Induced YOY Decline in Heart Surgery Volumes in the US in 2020
  • COVID-19 Results in Colossal Backlog of Elective Surgeries & Extended Waiting Times
  • Pandemic Affects Demand for Central Venous Catheters (CVCs)
  • Central Venous Catheters Remain Crucial Element of COVID-19 Patients' Treatment
  • Central Venous Catheter (CVC): An Indispensable Medical Device for Healthcare Domain
  • Contradictions & Complications of CVCs
  • Types of Central Venous Catheters
  • Global Market Prospects & Outlook
  • Global Central Venous Catheters Market by Product Type (in %) for 2020E
  • Multi-Lumen Design Leads the CVCs Market
  • Antimicrobial Coated Catheters to Witness High Growth
  • Hospitals: The Largest End-Use Category
  • Developing Economies to Spearhead Long-term Growth
  • Competition
  • World Brands
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Chronic Diseases Necessitate Central Venous Access, Driving Demand for CVCs
  • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
  • World Diabetes and Population Statistics (2019, 2030 & 2045)
  • ESRD Prevalence Worldwide: Number of Treated ESRD Patients Per Million Population in Select Countries for 2019
  • Global Annual Medical Cost of CVD in US$ Billion: 2010, 2015, 2020, 2025 and 2030
  • Aging Population with Higher Susceptibility to Age-related Chronic Conditions to Drive Market Gains
  • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
  • Life Expectancy at Age 60 and 80 Years: (2010-2015), (2020-2025) & (2045-2050)
  • Use of Central Venous Catheterization for Chemotherapy Administration Boosts Market Growth
  • Catheters Hold Vital Role in Drugs & Fluid Delivery in Cancer Treatment
  • Expanding Patient Population Diagnosed with Renal Diseases: Potential Growth for CVCs Market
  • Global Dialysis Patient Population Breakdown by Geographic Region/Country (2019 and 2024)
  • Catheter-Related Infections during Hemodialysis Reduce due to Hygiene Procedures
  • Percutaneous Translumbar Insertion for Alternate Venous Access for Dialysis of COVID-19 ARDS Patients
  • Surgical Procedure Volumes and Shift towards Minimal Invasive Surgeries: Significant Impact on CVCs Market
  • Global Volume of Surgical Procedures (in Million) by Category: 2019
  • Growth in the Number of Surgeries in the US (2010-2020) and 2001-2010 (in %)
  • Number of Surgical Procedures (per 100,000 People) in Select Countries
  • Central Venous Catheters: Playing Critical Role in Parenteral Nutrition
  • Growing Role of Central Venous Catheters in Drug Administration
  • Rising Use of Central Venous Catheters in ICU Settings
  • Growing Adoption of Antimicrobial Impregnated Catheters
  • Technologically Advanced CVCs Promise Better Outcomes for Interventional Procedures
  • 3M Korea's All-in-One PICC/CVC Securing System
  • Clear Correlation between CVD Risk and Central Venous Catheter Insertion Calls for Minimization of Catheter Use
  • Consistent Rise in Healthcare Spending Worldwide to Drive Market Opportunities
  • World Healthcare Expenditure (In US$ Trillion) for the Years for 2017, 2019, 2021 and 2023
  • Elderly Healthcare Expenditure as a % of GDP in the US, Europe and Japan for 1970, 2010 and 2050
  • Challenges Facing Central Venous Catheters Market
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Central Venous Catheters (CVCs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Central Venous Catheters (CVCs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Multi-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Multi-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Triple-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Triple-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Double-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Double-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Single-Lumen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Single-Lumen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Non-Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Non-Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 19: World Recent Past, Current & Future Analysis for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World Historic Review for Antimicrobial Coated by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: World 15-Year Perspective for Antimicrobial Coated by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 22: World Recent Past, Current & Future Analysis for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 23: World Historic Review for Jugular Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: World 15-Year Perspective for Jugular Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 25: World Recent Past, Current & Future Analysis for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 26: World Historic Review for Femoral Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: World 15-Year Perspective for Femoral Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 28: World Recent Past, Current & Future Analysis for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 29: World Historic Review for Subclavian Vein by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: World 15-Year Perspective for Subclavian Vein by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 31: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 32: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 34: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 35: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
CANADA
JAPAN
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
CHINA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
EUROPE
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
FRANCE
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
GERMANY
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
ITALY
UNITED KINGDOM
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Central Venous Catheters (CVCs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION
  • Total Companies Profiled: 61

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Amecath
  • AngioDynamics Inc.
  • B. Braun Melsungen AG
  • Bactiguard AB
  • Becton, Dickinson and Company
  • COOK MEDICAL LLC
  • Edwards Lifesciences Corporation
  • Guangdong Baihe Medical Technology Co., Ltd
  • ICU Medical, Inc.
  • Insung Medical Co. Ltd.
  • KIMAL PLC
  • Lepu Medical Technology (Beijing) Co., Ltd.
  • Medtronic Plc
  • Smiths Medical, Inc.
  • Teleflex Incorporated
  • Vygon Ltd
  • ZOLL Medical Corporation